نتایج جستجو برای: ifnl3

تعداد نتایج: 233  

Journal: :Human immunology 2012
Satoru Joshita Takeji Umemura Yoshihiko Katsuyama Yuki Ichikawa Takefumi Kimura Susumu Morita Atsushi Kamijo Michiharu Komatsu Tetsuya Ichijo Akihiro Matsumoto Kaname Yoshizawa Nozomi Kamijo Masao Ota Eiji Tanaka

IL28B single nucleotide polymorphisms (SNPs) are associated with spontaneous and treatment-induced elimination of hepatitis C virus (HCV). To assess whether the IL28B rs8099917 SNP also affects the progression of chronic HCV infection, we genotyped 511 Japanese HCV patients, including 69 with hepatocellular carcinoma (HCC). The T/T genotype of rs8099917 was not associated with the development o...

2015
Jing Chen Wei Wang Xiaoguang Li Jie Xu

BACKGROUND Several association studies with small sample sizes of two SNPs in IL28BB (rs12979860 and rs8099917) showed inconsistent results, so in this study, we aim to evaluate the association between the two SNPs and infection susceptibility of Hepatitis B Virus (HBV) in Asian population, especially in Chinese population by meta-analysis. METHODS Search the relevant published papers and per...

Journal: :The Journal of general virology 2013
Cristina Bucci Annette von Delft Annabel Christian Vicki M Flemming Abby Harrison John Halliday Jane Collier Chris Manganis Paul Klenerman William Irving Eleanor Barnes

IL28B host genetic make-up is known to play a critical role in the outcome of genotype 1 hepatitis C virus (HCV) infection in the context of both primary infection and therapy. However, the role of IL28B in subtype 3a infection remains unclear, and has not yet been assessed in the UK population where subtype 3a is dominant. In this study, we evaluated the role of the IL28B single-nucleotide pol...

Journal: :Antiviral therapy 2014
Elisabetta Degasperi Luca Valenti Alessio Aghemo Raffaele De Francesco Mariagrazia Rumi Roberta Soffredini Lorena Donnici Cristina Cheroni Silvia Fargion Valeria Zanoni Emanuela Orsi Massimo Colombo

BACKGROUND In patients with chronic HCV infection, an association between IL28B genotype and insulin-resistance (IR), known predictors of sustained virological response (SVR) to pegylated interferon (PEG-IFN) and ribavirin (RBV) therapy, has been reported. The aim of this study was to investigate the association of IR and IL28B genotype in two cohorts of well-characterized HCV patients. METHO...

2016
Renwen Zhang Cuiping Shao Na Huo Minran Li Xiaoyuan Xu

BACKGROUND/AIMS Several studies have demonstrated that serum interferon-γ-inducible-protein-10 (IP-10) levels at baseline and single nucleotide polymorphisms (SNPs) near the IL28B gene were associated with viral response and treatment outcomes. Our purpose was to assess the combination of pretreatment IP-10 levels with IL28B SNPs as predictors of treatment response to pegylated interferon α-2a ...

2011
Tatsuo Miyamura Tatsuo Kanda Shingo Nakamoto Shuang Wu Keiichi Fujiwara Fumio Imazeki Osamu Yokosuka

BACKGROUND We investigated associations between signal transducer and activator of transcription (STAT) 1 in pretreated liver tissues, interleukin (IL) 28B polymorphism and treatment response in hepatitis C virus (HCV)-infected patients treated with peginterferon and ribavirin. METHODS AND FINDINGS We performed immunostaining analysis of STAT1 in liver tissues and determined IL28B polymorphis...

Journal: :Balkan medical journal 2015
Serpil Taheri Bilgehan Aygen Keziban Korkmaz Orhan Yıldız Gökmen Zararsız Halit Canatan

BACKGROUND Host genetic factors can affect the progress of hepatitis-C virus (HCV) infection. Interleukin-28B (IL28B) single nucleotide polymorphisms may play an important role in the clearance of HCV spontaneously or with treatment. AIMS The aim of our study was to evaluate the rate of IL28B genotypes in patients with Chronic Hepatitis-C (CHC) and healthy control subjects and to examine the ...

2012
Francesc Vidal Miguel López-Dupla Montserrat Laguno Sergi Veloso Josep Mallolas Javier Murillas Carmen Cifuentes Lluis Gallart Teresa Auguet Gloria Sampériz Antoni Payeras Pilar Hernandez Mireia Arnedo Josep Ma Gatell Cristóbal Richart

BACKGROUND AND AIMS This was a safety and efficacy pharmacogenetic study of a previously performed randomized trial which compared the effectiveness of treatment of hepatitis C virus infection with pegylated interferon alpha (pegIFNα) 2a vs. 2b, both with ribavirin, for 48 weeks, in HCV-HIV coinfected patients. METHODS The study groups were made of 99 patients (efficacy pharmacogenetic substu...

2016
Ming-Ying Lu Ching-I Huang Ming-Yen Hsieh Tusty-Juan Hsieh Edward Hsi Pei-Chien Tsai Yi-Shan Tsai Ching-Chih Lin Meng-Hsuan Hsieh Po-Cheng Liang Yi-Hung Lin Nai-Jen Hou Ming-Lun Yeh Chung-Feng Huang Zu-Yau Lin Shinn-Cherng Chen Jee-Fu Huang Wan-Long Chuang Chia-Yen Dai Ming-Lung Yu

Hepatitis C virus (HCV) can replicate in peripheral blood mononuclear cells (PBMCs), which can produce interferon to defend against virus infection. We hypothesized that dynamic gene expression in PBMCs might impact the treatment efficacy of peginterferon/ribavirin in HCV patients. PBMCs were collected at baseline, 1st week and 4th week of treatment from 27 chronic HCV-1 patients with 48-week p...

2015
Elena L. Enache Anca Sin Ligia Bancu Christophe Ramière Olivier Diaz Patrice André Liviu S. Enache Emil Alexov

Chronic hepatitis C (CHC) is a major burden for public health worldwide. Although newer direct-acting antivirals show good efficacy, their cost precludes their wide adoption in resource-limited regions. Thus, strategies are being developed to help identify patients with high susceptibility to response to classic PEG-interferon + ribavirin therapy. IL28B polymorphism rs12979860 C/T is an importa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید